Safety, Tolerability, Pharmacokinetic s, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
JOURNAL OF ALZHEIMERS DISEASE（2022）
关键词
ATH-1001,ATH-1017,Alzheimer's disease,dementia,fosgonimeton,hepatocyte growth factor,electroencephalography,event-related potentials,P300 component,neurotrophic factor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要